CLINICAL_TRIALS
trial_result
· 2013-01-01
Clinical Trial Update: Effect of Erythropoietin on the Incidence of Acute Kidney Injury Following Complex Valvular Heart Surgery [Phase 2]
Summary
A Phase 2 trial evaluating erythropoietin to reduce acute kidney injury after complex valvular heart surgery has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yonsei University | Conditions: Acute Kidney Injury | Phase 2 | Status: COMPLETED